Gara Jalqabaatti › Aartiriitii Dargaggoo
Qorannoo klinikaalii Aartiriitii Dargaggoo Ameerikaa Keessatti hirmaatuu
Qorannoo 17 Aartiriitii Dargaggoo f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Washington, DCQorannoo 6
- Cincinnati, OHQorannoo 6
- Portland, ORQorannoo 5
- New York City, NYQorannoo 4
- Salt Lake City, UTQorannoo 4
- Pittsburgh, PAQorannoo 4
- Cleveland, OHQorannoo 3
- Gainesville, FLQorannoo 3
- Indianapolis, INQorannoo 3
Naannoon
- CaliforniaQorannoo 3
- Distaarikii KoloombiyaaQorannoo 4
- FloridaQorannoo 4
- IndianaQorannoo 3
- New YorkQorannoo 5
- North CarolinaQorannoo 3
- OhioQorannoo 8
- OregonQorannoo 5
- PennsylvaniaQorannoo 4
- TexasQorannoo 4
- UtahQorannoo 4
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
Natural History and Development of Spondyloarthritis
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 2 hanga 99 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT01422694Allogeneic Hematopoietic Cell Transplantation for Refractory Systemic Juvenile Idiopathic Arthritis.
Namoota walitti qabaa jiraQorannoo ilaalaa
Hanga umuriin 35 · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT07845942Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 2 hanga 17 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06751238Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 2 hanga 21 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06654882A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's Disease
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 1 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07203001A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 3 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06663332Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 1 hanga 17 · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT05609630Hemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE Study
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 120 · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT06339177A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 5 hanga 17 · Saalaa hunda · Haaromfame 01-Ful-2026 · NCT06100744Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
Hanga umuriin 21 · Saalaa hunda · Haaromfame 27-Hag-2026 · NCT02418442Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 5 hanga 21 · Saalaa hunda · Haaromfame 24-Ado-2026 · NCT04833465Pain in Juvenile Arthritis
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 9 hanga 17 · Saalaa hunda · Haaromfame 14-Ado-2026 · NCT07217782Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ado-2026 · NCT07138898The BRIDGE Pain Study
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 14 hanga 26 · Saalaa hunda · Haaromfame 22-Cam-2026 · NCT07602595Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 2 fi ol · Saalaa hunda · Haaromfame 22-Ama-2026 · NCT04806620Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
Namoota walitti qabaa jiraSadarkaa 2
2 Months – 55 Years · Saalaa hunda · Haaromfame 15-Mud-2025 · NCT01962415Quantification & Classification of Inflammatory Cells in Uveitis Using OCT
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 5 hanga 85 · Saalaa hunda · Haaromfame 17-Ado-2025 · NCT07065747Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.